Biora Therapeutics Inc (BIOR) — Cash Flow-to-Debt Ratio
Biora Therapeutics Inc (BIOR) has a Cash Flow-to-Debt Ratio of -0.07x as of September 2024, meaning its operating cash flow of $-8.73 Million could theoretically repay 0% of its total liabilities ($121.13 Million) in one year. Explore BIOR long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biora Therapeutics Inc Cash Flow-to-Debt Ratio (2018–2023)
Historical debt coverage capacity for Biora Therapeutics Inc across 6 annual periods. Also explore how large is Biora Therapeutics Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Biora Therapeutics Inc (2018–2023)
Year-by-year debt coverage analysis for Biora Therapeutics Inc. For market capitalisation and broader financial context, see market cap of Biora Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.37x | $-48.50 Million | $132.64 Million | ▲ +11.6% |
| 2022 | -0.41x | $-64.42 Million | $155.81 Million | ▲ +52.2% |
| 2021 | -0.86x | $-167.49 Million | $193.81 Million | ▼ -36.3% |
| 2020 | -0.63x | $-165.74 Million | $261.43 Million | ▼ -10.9% |
| 2019 | -0.57x | $-106.12 Million | $185.60 Million | ▼ -34.6% |
| 2018 | -0.42x | $-65.13 Million | $153.37 Million | — |